Literature DB >> 11923169

Statins as the new aspirin. Conclusions from the heart protection study were premature.

Uffe Ravnskov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923169      PMCID: PMC1122718          DOI: 10.1136/bmj.324.7340.789

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Statins are the new aspirin, Oxford researchers say.

Authors:  Z Kmietowicz
Journal:  BMJ       Date:  2001-11-17

2.  Probability of adverse events that have not yet occurred: a statistical reminder.

Authors:  E Eypasch; R Lefering; C K Kum; H Troidl
Journal:  BMJ       Date:  1995-09-02

3.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

Authors:  I J Schatz; K Masaki; K Yano; R Chen; B L Rodriguez; J D Curb
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

4.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

Review 5.  Carcinogenicity of lipid-lowering drugs.

Authors:  T B Newman; S B Hulley
Journal:  JAMA       Date:  1996-01-03       Impact factor: 56.272

  5 in total
  1 in total

1.  Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.

Authors:  R K Simmons; A H Carlsen; S J Griffin; M Charles; J S Christiansen; K Borch-Johnsen; A Sandbaek; T Lauritzen
Journal:  Diabet Med       Date:  2014-09-29       Impact factor: 4.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.